The constitutive and dsRNA-induced expression of RIG-I and MDA5 has been described in FLS from RA patients, and our results have shown that VIP is able to inhibit significantly the dsRNA-induced gene expression of RIG-I [47] (Figure 1). The gene discussed is VIP; the disease is rheumatoid arthritis.